The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Dopamine-Non-Responsive Symptoms of Parkinson's Disease, 2006Non-dopaminergic imaging biomarkers as tools for early PD - testing the Braak Hypothesis
Many recent studies have suggested that we need to expand research in Parkinson's disease to study symptoms other than the typical motor symptoms of tremor, slowness of movements, stiffness, and...
-
Dopamine-Non-Responsive Symptoms of Parkinson's Disease, 2006Freezing in Parkinson’s Disease: Clinical, Electrophysiological and Therapeutic Studies
Gait disorders and Freezing of Gait (FOG) are among the very common, disabling and poorly understood symptoms of Parkinson's disease. FOG is a debilitating phenomenon in which the person is suddenly...
-
Dopamine-Non-Responsive Symptoms of Parkinson's Disease, 2006Treadmill Training and Gait-Related Disability in Parkinson’s Disease
Gait impairment resulting in loss of mobility is a major cause of disability in Parkinson's disease, and current therapy including levodopa, surgery and rehabilitation are inadequate to preserve...
-
Prescott Family Initiative at the Arizona Parkinson's Diseas, 2006The Prescott Family Initiative at The Arizona Parkinson's Disease Consortium
Parkinson's disease is currently diagnosed clinically by finding slowness of movement along with either rest tremor or rigidity. However, the only way to definitively diagnose PD is by autopsy. In...
-
Community Fast Track, 2006The Inhibition of Neurotransmitter Release by Alpha-synuclein
Although current therapy manages the symptoms of Parkinson's disease, we still understand very little about the underlying mechanism of degeneration, and hence have no treatment that addresses the...
-
Community Fast Track, 2006D3 Receptor Selective Drugs for Parkinson's Dyskinesia
Biomedical research has defined two categories of dopamine receptors, the D1-like (D1 and D5 receptor subtypes) and D2-like (D2, D3 and D4 receptor subtypes) receptors. Despite the similarities in the...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.